Earningsreport

Q2/2024 6/30/2024 EPS 0.020 ZacksConsensus -0.250 ActVsEst 0.270 - Beat

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors